— Know what they know.
Not Investment Advice

Financial News

Sentiment 43.1 5419 articles 2840 bullish 1163 bearish Full Index →
HC Wainwright Brokers Raise Earnings Estimates for SLDB

HC Wainwright Brokers Raise Earnings Estimates for SLDB

Solid Biosciences Inc. (NASDAQ:SLDB – Free Report) – Equities researchers at HC Wainwright boosted their Q1 2026 earnings per share...
What is Northland Securities’ Estimate for TLSI Q1 Earnings?

What is Northland Securities’ Estimate for TLSI Q1 Earnings?

TriSalus Life Sciences, Inc. (NASDAQ:TLSI – Free Report) – Investment analysts at Northland Securities lowered their Q1 2026 EPS...
Perspective Therapeutics Q1 EPS Boosted by HC Wainwright

Perspective Therapeutics Q1 EPS Boosted by HC Wainwright

Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX – Free Report) – Equities researchers at HC Wainwright raised their Q1 2026 earnings...
Zacks Research Expects Lower Earnings for Editas Medicine

Zacks Research Expects Lower Earnings for Editas Medicine

Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) – Analysts at Zacks Research dropped their Q2 2026 earnings estimates for Editas...
HC Wainwright Cuts Earnings Estimates for Coya Therapeutics

HC Wainwright Cuts Earnings Estimates for Coya Therapeutics

Coya Therapeutics, Inc. (NASDAQ:COYA – Free Report) – Analysts at HC Wainwright dropped their Q1 2026 earnings per share (EPS) estimates...
What is HC Wainwright’s Estimate for Adicet Bio Q1 Earnings?

What is HC Wainwright’s Estimate for Adicet Bio Q1 Earnings?

Adicet Bio, Inc. (NASDAQ:ACET – Free Report) – Equities research analysts at HC Wainwright raised their Q1 2026 EPS estimates for shares...
Q1 Earnings Estimate for ELDN Issued By Noble Financial

Q1 Earnings Estimate for ELDN Issued By Noble Financial

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Free Report) – Stock analysts at Noble Financial issued their Q1 2026 earnings per share...
Drägerwerk AG & Co. KGaA Q4 Earnings Call Highlights

Drägerwerk AG & Co. KGaA Q4 Earnings Call Highlights

Drägerwerk AG & Co. KGaA (ETR:DRW3) reported record net sales and sharply higher earnings for fiscal 2025, with management pointing to...
Litchfield Hills Research Comments on Star Equity Q1 Earning

Litchfield Hills Research Comments on Star Equity Q1 Earnings

Star Equity Holdings, Inc. (NASDAQ:STRR – Free Report) – Research analysts at Litchfield Hills Research issued their Q1 2026 earnings per...
Reviewing Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) an

Reviewing Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Sensus Healthcare (NASDAQ:SRTS)

Sensus Healthcare (NASDAQ:SRTS – Get Free Report) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS – Get Free Report) are both...
Novo Chairman Faces Testy Investors With Little Progress So

Novo Chairman Faces Testy Investors With Little Progress So Far

Novo Nordisk A/S’s Chairman Lars Rebien Sorensen will face investors at the company’s annual meeting for the first time on Thursday after his...
Super Micro Computer Hit With Securities Fraud Lawsuit Amid

Super Micro Computer Hit With Securities Fraud Lawsuit Amid Alleged China Sales Cover-Up And Nvidia Chip Smuggling Scandal

Super Micro Computer (NASDAQ:SMCI) is facing a class-action lawsuit. The server maker is accused of misleading investors about exposure to China and...
Cathie Wood Chooses Medical AI Over Mark Zuckerberg: Ark Loa

Cathie Wood Chooses Medical AI Over Mark Zuckerberg: Ark Loads Up On TEM Stock, Dumps Meta Shares

On Wednesday, Cathie Wood-led Ark Invest made significant trades, notably involving Tempus AI Inc (NASDAQ:TEM) and Meta Platforms...
📰

Soleno Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Soleno Therapeutics, Inc. - SLNO

NEW ORLEANS, March 25, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 5,...
Jack Dorsey Once Revealed He Sounded 'Gibberish' As A Child

Jack Dorsey Once Revealed He Sounded 'Gibberish' As A Child — The Twitter Founder Did This After Realizing He Couldn't 'Function' Like That

Jack Dorsey once revealed that early struggles with speech and shyness pushed him to deliberately pursue—and try to master—the art of...
Urban-gro, DraftKings, Sarepta Therapeutics, Destiny Tech100

Urban-gro, DraftKings, Sarepta Therapeutics, Destiny Tech100 And AMD: Why These 5 Stocks Are On Investors' Radars Today

U.S. stocks closed higher on Wednesday, with the Dow Jones Industrial Average up 0.66% at 46,429.49, the S&P 500 gaining 0.5% to 6,591.90 and the...
📰

Surging Oil Prices Spark Market Jitters

The Motley Fool's Hidden Gems team discusses some historical disruptions in the energy market, how trends in semiconductors are reshaping the S&P...
📰

Surging Oil Prices Spark Market Jitters

The Motley Fool's Hidden Gems team discusses some historical disruptions in the energy market, how trends in semiconductors are reshaping the S&P...
📰

Surging Oil Prices Spark Market Jitters

The Motley Fool's Hidden Gems team discusses some historical disruptions in the energy market, how trends in semiconductors are reshaping the S&P...
📰

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BSX

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p...
📰

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Atara Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATRA

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p...
📰

MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2025 Financial Results

TORONTO, March 25, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB:MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the...
📰

Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <ul...
📰

Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates

ROCKVILLE, Md. and SUZHOU, China, March 25, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (Ascentage Pharma) (NASDAQ: AAPG; HKEX:...
📰

POMDOCTOR CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against PomDoctor, Ltd. and Encourages Stockholders to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In PomDoctor (POM) To Contact Him Directly...
📰

AtlanTech Vision Files Provisional Patent for PVD™ HemiComb™ - Minimalist Glasses-Free Light-Field Displays

AtlanTech Vision Corporation (ATVICO) today announced the successful filing of a U.S. Provisional Patent Application for its groundbreaking PVD™...
📰

Palvella Stock Up 340% as Insider Sells Shares. Here's What the Move Does (And Does Not) Signal

This clinical-stage biotech advancing therapies for rare skin diseases reported a notable insider sale amid a year of sharp stock gains.
📰

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p...
Draganfly Stock Sheds 21% Post-Earnings — Here's Why It's St

Draganfly Stock Sheds 21% Post-Earnings — Here's Why It's Still A Buy

Shares of drone tech company Draganfly Inc. (NASDAQ:DPRO) sold off hard on Wednesday after disappointing fourth-quarter earnings — but the report and...
📰

MREO FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p...
📰

Why Medpace (MEDP) Outpaced the Stock Market Today

In the closing of the recent trading day, Medpace (MEDP) stood at $466.8, denoting a +1.32% move from the preceding trading day.
📰

ROSEN, HIGHLY REGARDED INVESTOR RIGHTS COUNSEL, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLNO

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p...
📰

Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Inovio Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Inovio (INO) To Contact Him Directly To...
📰

Dyadic (DYAI) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool.Wednesday, March 25, 2026 at 5 p.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading
📰

Oscar Health, Inc. (OSCR) Outpaces Stock Market Gains: What You Should Know

Oscar Health, Inc. (OSCR) concluded the recent trading session at $12.21, signifying a +1.5% move from its prior day's close.
📰

Is Pfizer Stock a Buy After This Win?

Good news has been scarce for this beaten-down drugmaker.
📰

Vertex Pharmaceuticals (VRTX) Laps the Stock Market: Here's Why

Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $454.97, signifying a +1.42% move from its prior day's close.
📰

Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know

In the most recent trading session, Amgen (AMGN) closed at $353.93, indicating a +1.58% shift from the previous trading day.
« Prev 1 8 9 10 11 12 82 Next »

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms